Cetera Investment Advisers Buys New Position in UFP Technologies, Inc. (NASDAQ:UFPT)

Cetera Investment Advisers bought a new position in shares of UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,391 shares of the industrial products company's stock, valued at approximately $340,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Wasatch Advisors LP raised its stake in UFP Technologies by 37.1% during the fourth quarter. Wasatch Advisors LP now owns 576,691 shares of the industrial products company's stock worth $141,007,000 after buying an additional 156,142 shares during the last quarter. Boston Trust Walden Corp acquired a new stake in UFP Technologies during the 4th quarter worth about $26,395,000. Raymond James Financial Inc. bought a new position in shares of UFP Technologies in the 4th quarter worth about $16,808,000. Price T Rowe Associates Inc. MD lifted its stake in shares of UFP Technologies by 55.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 178,411 shares of the industrial products company's stock valued at $43,625,000 after purchasing an additional 63,899 shares during the period. Finally, Franklin Resources Inc. boosted its position in shares of UFP Technologies by 48.1% during the 4th quarter. Franklin Resources Inc. now owns 136,345 shares of the industrial products company's stock valued at $33,338,000 after purchasing an additional 44,292 shares in the last quarter. 87.28% of the stock is owned by institutional investors.

UFP Technologies Stock Down 2.7%

UFPT stock traded down $6.21 during trading on Monday, reaching $227.99. 390,397 shares of the stock were exchanged, compared to its average volume of 91,657. The firm's 50 day moving average is $216.66 and its 200 day moving average is $243.31. The firm has a market cap of $1.76 billion, a P/E ratio of 32.61 and a beta of 1.10. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64. UFP Technologies, Inc. has a twelve month low of $178.26 and a twelve month high of $366.41.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The industrial products company reported $2.47 EPS for the quarter, beating the consensus estimate of $2.05 by $0.42. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%. The firm had revenue of $148.15 million during the quarter, compared to the consensus estimate of $139.93 million.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on UFPT shares. Lake Street Capital set a $252.00 price target on UFP Technologies and gave the company a "buy" rating in a research note on Wednesday, May 7th. Raymond James started coverage on shares of UFP Technologies in a research note on Friday, March 28th. They issued a "market perform" rating for the company.

Insider Buying and Selling at UFP Technologies

In other news, SVP Christopher P. Litterio sold 1,473 shares of UFP Technologies stock in a transaction dated Thursday, May 8th. The shares were sold at an average price of $220.12, for a total transaction of $324,236.76. Following the completion of the transaction, the senior vice president now directly owns 12,585 shares in the company, valued at $2,770,210.20. This trade represents a 10.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.40% of the stock is currently owned by company insiders.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.